Mianserin-induced down-regulation of human 5-hydroxytryptamine(2A) and 5-hydroxytryptamine(2C) receptors stably expressed in the human neuroblastoma cell line SH-SY5Y

Journal of Neurochemistry

Volumn 69, Issue 3, 1997, Pages 1031-1038

  Newton, R A ^a   Elliott, J M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antagonist; Human serotonin receptors; Modulation; Serotonin 5 HT(2A) and 5 HT(2C) receptor subtypes

Indexed keywords

SEROTONIN 1C RECEPTOR; SEROTONIN 2A RECEPTOR;

ARTICLE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; SEROTONINERGIC NERVE CELL;

EID: 0030855796     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69031031.x     Document Type: Article

References (34)

1. 1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Mol. Pharmacol. 44, 725-730.
2. 2C receptors reveal novel inverse agonist activity of receptor ligands. J. Biol. Chem. 269, 11887-11890.
3. Blackshear M. A. and Sanders-Bush E. (1982) Serotonin receptor sensitivity after acute and chronic treatment with mianserin. J. Pharmacol. Exp. Ther. 221, 303-308.
4. Blackshear M. A., Friedman R. L., and Sanders-Bush E. (1983) Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sites. Naunyn Schmiedebergs Arch. Pharmacol. 324, 125-129.
5. 2 binding site after chronic administration of agonists and antagonists. Neuropharmacology 25, 1267-1271.
6. 2 receptors. Life Sci. 42, 2439-2445.
7. Conn P. J. and Sanders-Bush E. (1986) Agonist-induced phosphoinositide hydrolysis in choroid plexus. J. Neurochem. 47, 1754-1760.
8. Eison A. S., Eison M. S., Yocca F. D., and Gianutsos G. (1989) Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation. Life Sci. 44, 1419-1427.
9. el-Fakahany E. E. and Cioffi C. L. (1990) Molecular mechanisms of regulation of neuronal muscarinic receptor sensitivity. Membr. Biochem. 9, 9-27.
10. 2A receptor-activated cascade in rat C6 glioma cells. Neuroscience 69, 1119-1131.
11. 2 receptors in P11 cells. Mol. Pharmacol. 43, 726-733.
12. 2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. Br. J. Pharmacol. 83, 235-242.
13. Kuoppamaki M., Seppala T., Syvalahti E., and Hietala J. (1993) Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol. J. Pharmacol. Exp. Ther. 264, 1262-1267.
14. 2C receptors in the rat choroid plexus after acute clozapine treatment. Eur. J. Pharmacol. 269, 201-208.
15. 2 antagonists: ritanserin and setoperone. Psychopharmacology 88, 434-444.
16. 2 receptors by DOM treatment. Eur. J. Pharmacol. 163, 145-149.
17. Lohse M. J. (1993) Molecular mechanisms of membrane receptor desensitization. Biochim. Biophys. Acta 1179, 171-188.
18. 1C receptors. Eur. J. Pharmacol. 183, 1617.
19. 2A receptors expressed in SH-SY5Y human neuroblastoma cells. Br. J. Pharmacol. (in press).
20. 2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs. J. Neurochem. 67, 2521-2531.
21. Peterson G. L. (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83, 346-356.
22. 1C/2 receptor agonists and antagonists. Eur. J. Pharmacol. 244, 1-5.
23. 2 receptor mRNA levels. Eur. J. Pharmacol. 207, 169-172.
24. 1C) receptors. Biol. Psychiatry 25, 42A.
25. Sanders-Bush E. (1990) Adaptive regulation of central serotonin receptors linked to phosphoinositide hydrolysis. Neuropsychopharmacology 3, 411-416.
26. 1C receptors in choroid plexus. J. Pharmacol Exp. Ther. 247, 169-173.
27. 1C receptor reserve in choroid plexus masks receptor subsensitivity. J. Pharmacol. Exp. Ther. 252, 984-988.
28. 2 binding sites after mianserin: comparison of loss of sites and brain levels of drug. Eur. J. Pharmacol. 133, 199-204.
29. Sato M., Kataoka R., Dingus J., Wilcox M., Hildebrandt J. D., and Lanier S. M. (1995) Regulation of signal transfer from receptor to G-protein. J. Biol. Chem. 270, 15269-15276.
30. 2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behaviour. J. Pharmacol. Exp. Ther. 254, 484-488.
31. Spurlock G., Buckland P., Odonovan M., and Mcguffin P. (1994) Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter. Neuropharmacology 33, 433-440.
32. Steel M. C. and Buckley N. J. (1993) Differential regulation of muscarinic receptor mRNA levels in neuroblastoma cells by chronic agonist exposure: a comparative polymerase chain reaction study. Mol. Pharmacol. 43, 694-701.
33. Toth M. and Shenk T. (1994) Antagonist-mediated down-regulation of 5-hydroxytryptamine type 2 receptor gene expression: modulation of transcription. Mol. Pharmacol. 45, 1095-1100.
34. Vallar L., Muca C., Magni M., Albert P., Bunzow J., Meldolesi J., and Civelli O. (1990) Differential coupling of dopaminergic D2 receptors expressed in different cell types. Stimulation of phosphatidylinositol 4,5-bisphosphate hydrolysis in LtK-fibroblasts, hyperpolarization, and cytosolic-free Ca2+ concentration decrease in GH4C1 cells. J. Biol. Chem. 265, 10320-10326.